Investigation to Explain Bioequivalence Failure in Pravastatin Immediate-Release Products

The purpose of this work is to explore the predictive ability of the biopharmaceutics classification system (BCS) biowaiver based on the dissolution methods for two pravastatin test products, where one of them showed bioequivalence (BE) while the other test failed (non-bioequivalence, or NBE), and t...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Pharmaceutics 2019-12, Vol.11 (12), p.663
Hauptverfasser:	Ruiz-Picazo, Alejandro, Colón-Useche, Sarin, Perez-Amorós, Blanca, González-Álvarez, Marta, Molina-Martínez, Irene, González-Álvarez, Isabel, García-Arieta, Alfredo, Bermejo, Marival
Format:	Artikel
Sprache:	eng
Schlagworte:	Bioequivalence Cellulose Classification Dissolution Drug dosages Experiments Hypotheses Lactose Permeability Pharmaceutical industry Quality control Sodium
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!